• The Effects Of Metformin And Diabinese On Female Sex Hormone Of Type 2 Diabetes Mellitus Patients
    [UNIVERSITY OF ILORIN TEACHING HOSPITAL (UITH), ILORIN, KWARA STATE]

  • CHAPTER TWO -- [Total Page(s) 17]

    Page 1 of 17

    1 2 3 4 5    Next
    • CHAPTER TWO
      2.0                LITERATURE REVIEW
      2.1    DIABETES MELLITUS
      Diabetes mellitus is a complex, chronic disease. It is a condition characterised by an elevation of the level of glucose in the blood (IDF, 2012). Insulin, a hormone produced by the pancreas, controls the blood glucose level by regulating the production and storage of glucose (WHO, 2012). In diabetes there may be a decrease in the body’s ability to respond to insulin or a decrease in the insulin produced by the pancreas which leads to abnormalities in the metabolism of carbohydrates, proteins and fats (IDF, 2012).  The resulting hyperglycaemia may lead to acute metabolic complications including keto acidosis and in the long term contribute to chronic micro-vascular complications (Fauci et al., 2008). Fauci et al., (2008) define diabetes mellitus as a complex, chronic disorder characterised by disruption of normal carbohydrates, fat and protein metabolism and the development over time of micro-vascular and macro-vascular complications and neuropathies.
      American Diabetes Association (2008) defines diabetes mellitus as a metabolic disorder characterised by glucose intolerance. It is a systemic disease caused by an imbalance between insulin supply and insulin demand. The onset is from 3 years in children and 25 years in adults. According to Fauci et al., (2008), the criteria for diagnosis of diabetes mellitus have been explained and include a causal plasma glucose of 11.1mmo1/L or higher, or fasting plasma glucose of 7.0mmo1/L or higher. According to Baumann et al., (2002), the prevalence of diabetes is higher in minority groups and among those who are socio-economically disadvantaged, but the reason for that has not been given.
      2.1.1 TYPES OF DIABETES MELLITUS
      There are four major classifications of diabetes mellitus, namely: type I, type II type III and gestational diabetes.
      2.1.1.2     TYPE I
      This is known as insulin dependent diabetes mellitus. About 5-10% of patients have type I diabetes mellitus. The pancreas produces inadequate amounts of insulin, resulting in the need for insulin injections to control the blood glucose. It is characterised by a sudden onset, usually before the age of 30 years. (Rothe et al., 2008).
      According to Oster et al., (2016), in type I diabetes, also called IDDM, auto-immune B-cell destruction is attributed to a genetic predisposition coupled with viral agents and possibly chemical agents. Individuals susceptible to type I diabetes are linked to HLA (Human Leucocytes Antigen) DR3 and DR4 loci (DR3 and DR4 are just numbers used to identify the antigens).
      2.1.1.3     TYPE II
      This is also known as the non-insulin dependent diabetes mellitus (Garber, 2012). It results from a decrease in the sensitivity of the cells to insulin and a decrease in the amount of insulin produced. About 90-95% of patients have type II diabetes (Garber, 2012). This type II diabetes is treated with diet and exercise, and if elevated glucose levels persist, diet is supplemented with oral hypoglycaemic agents. During periods of illness or surgery, individuals who usually control their type II diabetes with diet, exercise and oral agents, may require insulin injections (Garber, 2012). In some individuals oral agents fail to control hyperglycaemia and insulin injection is required (Rothe et al., 2008).
      Funnell (2012), indicate that type II diabetes accounts for 80-90% of all cases and is the significant cause of morbidity in the United States. The complications of type II result in disruption of lifestyle, psychosocial adjustment and health care expenses. It is often treated with diet, exercise, self-monitoring of blood glucose and hypoglycaemic agents/insulin. Funnell (2012), indicate that there are two subtypes of type II, obese and non-obese. Type II has a strong genetic influence but there is no correlation with HLA (Human Leucocytes Antigen) type. Individuals with type II diabetes have a 50% chance of transmitting the disease to their children.
  • CHAPTER TWO -- [Total Page(s) 17]

    Page 1 of 17

    1 2 3 4 5    Next
    • ABSRACT - [ Total Page(s): 1 ]ABSTRACT is coming soon ... Continue reading---

         

      APPENDIX A - [ Total Page(s): 1 ]APPENDIX IQUESTIONNAIRE TO ACCESS THE ANTHROPOLOGIC AND DEMOGRAPHIC INDICES OF PATIENTS WITH TYPE TWO DIABETES MELLITUS ON ANTIDIABETIC DRUGS (METFORMIN AND DIABINESE) ATTENDING UITH ILORIN.INTRODUCTION: I am a final year students of the Department of Medical Laboratory Science, School of Basic Medical Sciences, Kwara State University, Malete, Kwara State. This questionnaire is aimed at accessing the demographic indices of patients with type 2 diabetes mellitus on metformin and diabinese in Ilor ... Continue reading---

         

      APPENDIX B - [ Total Page(s): 1 ]APPENDIX 11REAGENT COMPOSITION FOR ESTROGENEstrogen calibrates, Horseradish Peroxidase Conjugates, Estrogen biotinylated purified rabbit igG conjugates, Tetremethylbenzidine(TMB),  wash buffer concentrate, assay buffer, Stop solution.REAGENT COMPOSITION FOR PROGESTERONEProgesterone calibrates, Horseradish Peroxidase Conjugates, Progetarone biotinylated purified rabbit igG conjugates, Tetremethylbenzidine (TMB),  wash buffer concentrate, assay buffer, Stop solution. ... Continue reading---

         

      CHAPTER ONE - [ Total Page(s): 2 ]CHAPTER ONEINTRODUCTION1.1    BACKGROUND OF STUDY Diabetes mellitus is a group of metabolic disorders in which a person has high plasma glucose, either because the body does not produce enough insulin, or because cells do not respond to the insulin that is produced. The high plasma glucose produces the classical symptoms of polyuria, polydipsia and polyphagia (Rother, 2007). Type 2 diabetes mellitus, formerly non-insulin dependent diabetes mellitus or adult onset diabetes, is a ... Continue reading---

         

      CHAPTER THREE - [ Total Page(s): 6 ]3.7.2 REAGENT    Materials provided with the kit: 1.    Antibody-Coated Wells (1 plate, 96 wells) Microtiter wells coated with 1.0 µg/ml streptavidin was packaged in an aluminium.2.    Reference Standard Set (1ml/vial) Contains 0, 20, 100, 250, 500  1500,3000 in pg/ml with preservatives.3.    Rabbit Anti-estrogen Reagent (6 ml) Contains rabbit anti-estradiol biotinylated rabbit igG conjugate in buffer, yellow dye with preservatives.4.    Estradiol enzyme reagent (6 m ... Continue reading---

         

      CHAPTER FOUR - [ Total Page(s): 3 ]Table 4.4: Comparison of biochemical parameters (estrogen, progesterone and fasting blood sugar) between diabetic patients on metformin only and diabetic patients on combined metformin with other drugs (glimepride).Table 4.5 depicts the Pearson correlation of duration of diabetes and BMI with biochemical parameters (estrogen, progesterone and fasting blood sugar) in diabetic patients using antidiabetic drugs (metformin and diabinese).Data indicated a significant correlation between biochemical p ... Continue reading---

         

      CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0    DISCUSSIONType 2 diabetes mellitus, formerly known as non-insulin dependent diabetes mellitus or adult onset diabetes, is a metabolic disorder that is characterized by hyperglycemia in the context of insulin resistance and relative insulin deficiency (Vinay et al., 2008). Sex differences and the role of gonadal hormones in modulating insulin sensitivity and glucose tolerance are of increasing interest and importance because of the increasing prevalence of type 2 diabetes me ... Continue reading---

         

      REFRENCES - [ Total Page(s): 4 ]Murali, R. and Saravanan, R. (2012). Antidiabetic effect of d-limonene, a monoterpene in streptozotocin-induced diabetic rats. Biomedical Prevention and Nutrition.2:269-275.Neerati, P., Devde, R., and Gangi, A.K. (2014). Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytotherapeutic. Research. 28:1796-1800.Nelson, L.R. and Bulun, S.E. (2011).Estrogen production and action. Journal of America Academic and Dermatology. 4 ... Continue reading---